Clinical trial
NET-PD LS-1 Creatine in Parkinson's Disease
NCT00449865 · University of Rochester, Other · Terminated
Key facts
| NCT number | NCT00449865 |
|---|---|
| Title | NET-PD LS-1 Creatine in Parkinson's Disease |
| Official title | A Multicenter, Double-Blind, Parallel Group, Placebo Controlled Study of Creatine in Subjects With Treated Parkinson's Disease (PD) Long Term Study (LS-1) |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug, Other |
| Interventions | creatine, placebo |
| Enrollment | 1,741 |
| Start date | Mar 1, 2007 |
| Primary completion | Sep 1, 2013 |
| Completion | May 1, 2014 |
| First posted | Mar 21, 2007 |
| Last update posted | Apr 2, 2015 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: